M. Pedrocchi
- Oncology top 10%
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 1
- Cancer Research top 10%
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- S100 Proteins and Annexins 3
- Glycosylation and Glycoproteins Research 1
- Metabolomics and Mass Spectrometry Studies 1
- Protein Structure and Dynamics 1
-
- Biomarkers in Disease Mechanisms 1
- Co-authors
- Claus W. HeizmannGhizlane RouasAngelo Di LeoDenis LarsimontAlain VerhestFátima CardosoChantal Bernard-MartyMartine Piccart
- Partner nations
- SwitzerlandAustraliaGermany
In The Last Decade
M. Pedrocchi
7 papers receiving 594 citations
Peers
Comparison fields: 5 of 55
- Oncology 364
- Cancer Research 188
- Radiology, Nuclear Medicine and Imaging 159
- Immunology and Allergy 36
- Pulmonary and Respiratory Medicine 181
Countries citing papers authored by M. Pedrocchi
This map shows the geographic impact of M. Pedrocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Pedrocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Pedrocchi more than expected).
Fields of papers citing papers by M. Pedrocchi
This network shows the impact of papers produced by M. Pedrocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Pedrocchi. The network helps show where M. Pedrocchi may publish in the future.
Co-authorship network
The 23 scholars most cited alongside M. Pedrocchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. | 2003 | 146 |
| 2 | 2002 | 259 | |
| 3 | 2001 | 7 | |
| 4 | 1998 | 13 | |
| 5 | 1994 | 60 | |
| 6 | 1994 | 119 | |
| 7 | 1993 | 8 |
About M. Pedrocchi
M. Pedrocchi is a scholar working on Hepatology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Cell Biology, having authored 7 papers that have together received 612 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), S100 Proteins and Annexins (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), Protein Structure and Dynamics (1 paper), Peptidase Inhibition and Analysis (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Oncology (364 citations), Cancer Research (188 citations), Radiology, Nuclear Medicine and Imaging (159 citations), Immunology and Allergy (36 citations) and Pulmonary and Respiratory Medicine (181 citations). M. Pedrocchi has collaborated with scholars based in Switzerland, Australia and Germany. Frequent co-authors include Claus W. Heizmann, Ghizlane Rouas, Angelo Di Leo, Denis Larsimont, Alain Verhest, Fátima Cardoso, Chantal Bernard-Marty, Martine Piccart, David Gancberg and Marianne Paesmans. Their work appears in journals such as Biochemistry, Transfusion, International Journal of Cancer, Annals of Oncology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.